CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 2,333 shares at $0.92 ($2,146)
- 4 Grant or award Director acquired 611,224 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Commercial Officer sold 11,890 shares at $1.87 ($22,230)
- 4 Open-market sale Chief Patient Supply Officer sold 4,440 shares at $1.86 ($8,250)
- 4 Open-market sale Chief Operating Officer sold 4,440 shares at $1.86 ($8,250)
- 4 Open-market sale Chief Medical Officer sold 2,159 shares at $1.86 ($4,011)
- 4 Open-market sale Chief Executive Officer sold 10,057 shares at $1.86 ($18,686)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 18 · 351 filings